Cell replacement therapy offers a therapeutic approach for patients with advanced disease in which there has been loss of photoreceptors, RPE or retinal ganglion cells (RGCs). Age-related macular ...

Mature iPSC-derived RPE cells are visible by super resolution confocal microscopy. One primary cilium resides in the center of each cell. RPE cell borders are stained showing tight junction markers.

The NT-501 cell therapy implant contains allogeneic retinal pigment epithelium (RPE) cells. The implant has a semipermeable ...

What we have is a replica of the cells that are missing, due to degeneration.—Amir Kashani, University of Southern California The implant, given to five patients with dry age-related macular ...

In celebration of the 10th anniversary of the United Nations' International Day of Women and Girls in Science on 11th ...

Eyestem, a cell therapy company, on Tuesday announced that it has received approval from India’s Central Drugs Standards Control Organisation (CDSCO) to commence human trials for Eyecyte RPE.